Research links dromedary camels to MERS coronavirus

Approval granted for first-in-human study of MERS vaccine Courtesy of cdc.gov
Approval granted for first-in-human study of MERS vaccine - Courtesy of cdc.gov
0Comments

A international research team is advancing work that proves the Middle Eastern dromedary camel, long used for transportation and hauling, also transports and transmits several strains of Middle East Respiratory Syndrome (MERS) coronavirus.

The team, comprised of researchers from Egypt, Saudi Arabia, Hong Kong and mainland China, is examining the dromedary camel for the 229E coronavirus, known to comprise 1,300 cases, 500 of which have proven fatal to humans since 2012. The primary problem is bacterial evolution, meaning the disease takes one form while carried by a camel, is transmitted to humans in contact with an infected camel, then assumes a new form once affecting a human carrier — leading to additional human-to-human transmission.

Questions of disease severity and transmission rate in the study have their origin in the geographic location of the camel. Those local to Saudi Arabia, for example, have a MERS infection rate equal to that of a camel imported to Saudi Arabia from Africa or Dubai. This means the disease is not isolated to a geographic region, thereby directing research more toward biological abnormalities and susceptibility among groups of camels exhibiting symptoms more frequently than another group of camels.

Research suggests exact causes of MERS disease and transmission are not yet clear — but are advancing. Chiefly important are diligent reporting of illness among camels and prompt care for affected camels and humans. Additionally, new vaccine candidates are emerging as this research continues, with candidates likely inside of three or four months.



Related

dummy-img

380 people die in New York state from heart disease in week ending March 12

There were 380 deaths with heart disease listed as the underlying cause reported in New York state during the week ending March 12, a 3.3 percent decrease from the previous week.

dummy-img

70 people die in New York state with COVID-19 listed as the underlying cause in week ending March 12

There were 70 deaths with COVID-19 listed as the underlying cause reported in New York state during the week ending March 12, a 20.5 percent decrease from the previous week.

dummy-img

29 people die in New York state from kidney disease in week ending March 12

There were 29 deaths with nephritis, nephrotic syndrome and nephrosis listed as the underlying cause reported in New York state during the week ending March 12, no changes from the previous week.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Vaccine News Daily.